期刊文献+

脑梗死患者血浆vWF、PLG、D-D含量变化与临床意义 被引量:5

Changes of plasma levels of vWF,PLG,D-D in patients with cerebral infraction and their clinical significance
下载PDF
导出
摘要 目的通过动态检测血浆血管性假血友病因子(vWF)、纤溶酶原(PLG)活性、D-二聚体(D-D)含量来探讨脑梗死患者病情变化与实验室指标的关系。方法测定48例脑梗死患者发病后第2d、第7d、第21d血浆中vWF、PLG、D-D水平,并与正常对照组36例进行比较。结果急性脑梗死患者发病后第2dvWF显著升高,随后逐渐下降,但是到21d仍然高于对照组;患者组血浆PLG水平第2d略高于对照组,差异无显著性意义(P>0.05),第7、21d均显著低于对照组(P<0.05);D-D含量一直高于对照组。结论测定上述指标可以判断急性脑梗死患者血管内皮细胞功能受损程度及纤溶系统激活情况,对患者病情诊断、治疗及预后均具有指导意义。 Objective To explore the relationship between the state of illness and plasma levels of vWF, PLG, D-D in patients whith cerebral infraction(CI). Methods The plasma levels of vWF,PLG and D-D were detected respectively at second, seventh, twenty-first days after onset in 48 patients with CI (CI group)and 36 health subjects (control group). Results The plasma level of vWF was signifi- cantly raised at second day after onset and then decreased gradually in CI group, but it was also high- er than that in control group at twenty-first day after onset. The plasma level of PLG between the two groups had no significant difference at second day, but it was significant lower than that in control group at seventh and twenty-first day after onset. The plasma levels of D-D in CI group were higher than those in control group after onset. Conclusion Detecting the plasma levels of vWF, PLG and D-D may be helpful in diagnosis, treatment and prognosis of the patients with CI.
出处 《现代实用医学》 2006年第9期618-620,共3页 Modern Practical Medicine
基金 温州市科委资助项目 项目编号Y2003A110
关键词 脑梗塞 D-二聚体 纤维蛋白溶酶原 血管性假血友病因子 Cerebral infraction yon Willebrand factor Plasminogen D-dimer
  • 相关文献

参考文献5

二级参考文献34

  • 1王鸿利,宋善俊.分子标志物在诊断血栓前状态的意义[J].国外医学(输血及血液学分册),1995,18(2):68-72. 被引量:67
  • 2于光耀.血管内皮功能障碍与动脉粥样硬化[J].中国动脉硬化杂志,1996,4(2):145-148. 被引量:20
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 4曹赞孙 苟文丽.现代围产医学[M].北京:人民卫生出版社,2000.403-405.
  • 5Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von willebrand factor. Blood, 1987, 70: 605-611
  • 6Wennmalm A, Nowak J, Bjuro T. Excretion of thromboxane A2 and prostacyclin metabolites before and after exercise testing in patients with and without signs of ischemic heart disease. Circulation, 1990, 82 (5): 1 737
  • 7刘泽霖, 贺石林, 李家增. 血栓性疾病的诊断与治疗. 北京: 人民卫生出版社, 2000; 82-90
  • 8Pizzo SV, Fuchs HE, Doman KA, Petruska DB, Berger H Jr. Release of tissue plasmiogen actvator and its fast-acting inhibitor in defective fibrinolysis. Arch Intern Med, 1986, 146: 188-191
  • 9Nadar SK,Yemeni EA,Blann AD,Lip GY.Thrombomodulin,von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.Thromb Res 2004; 113 (2):123-8
  • 10Ahmed RP,Gupta PK,Kannan M,et al.Hemophilia A:role of FVIIIC/vWF Ag in assisting linkage analysis for carrier detection.Clin Appl Thromb Hemost 2004; 10(2):127-31

共引文献33017

同被引文献36

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部